Implications of the accession of the Republic of Croatia to the European Union for Croatian health care system [Implikacije učlanjenja Republike Hrvatske u Europsku uniju na hrvatski zdravstveni sustav] by Ostojić, Rajko et al.
Coll. Antropol. 36 (2012) 3: 717–727
Original scientific paper
Implications of the Accession of the Republic
of Croatia to the European Union for Croatian
Health Care System
Rajko Ostoji}1, Vlatka Bilas2 and Sanja Franc2
1 University of Zagreb, School of Medicine, Zagreb, Croatia
2 University of Zagreb, Faculty of Economics and Business, Zagreb, Croatia
A B S T R A C T
The Republic of Croatia’s accession to the European Union (EU) will affect all segments of economy and society, in-
cluding the health care system. The aim of this paper is to establish the potential effects of joining the EU on Croatian
health care, as well as to assess its readiness to enter this regional economic integration. The paper identifies potential
areas of impact of EU accession on Croatian health care and analyzes the results of the conducted empirical research. In
this research, a method of in-depth interviews was applied on a sample of 49 subjects; health professionals from public
and private sectors, health insurance companies, pharmaceutical companies, drug wholesalers, and non-governmental
organisations (patient associations). Once Croatia joins the EU, it will face: new rules and priorities in line with the cur-
rent European health strategy; the possibilities of drawing funds from European cohesion funds; labour migrations; new
guidelines on patient safety and mobility. From the aspect of harmonising national regulations with EU regulations in
the area of health care, Croatian system can be assessed as ready to enter the EU. Croatia’s accession to the EU can result
in a better information flow, growth of competitiveness of Croatian health care system, enhanced quality, inflow of EU
funds, development of health tourism, but also in increased migration of health care professionals, and potential in-
crease in the cost of health care services. Functioning within the EU framework might result in adaptation to the EU
standards, but it could also result in the concentration of staff and institutions in larger cities.
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Introduction: The impact of the European
Union rules on health care systems in
member states
The Republic of Croatia’s accession to the European
Union (EU) will affect all segments of economy and soci-
ety, including the health care system. EU accession has
been set among Croatia’s priorities for a number of years
now. The official request to join the EU was submitted on
21 February 2003 and negotiations between EU member
states and Croatia began in October 2005 at the first ses-
sion of Intergovernmental Conference. After more than
eight years following the submission of the request and
almost six years of negotiations, accession negotiations
were closed on 30 June 2011, and the Treaty of Accession
was signed on 9 December 2011. Croatia is expected to
join the EU on 1 July 2013 when it should become the
28th member of this regional economic integration.
The relationship between European legislation and
health policy is a rather complex one, partially because
health policy does not have a clear delimitation between
the competences of member states and European institu-
tions. Because of specific historical reasons, the systems
of health and social welfare are for the most part not di-
rectly linked with the EU common policy and are conse-
quentially not part of the acquis communautaire. How-
ever, indirectly, almost all chapters of the acquis affect
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health in one way or the other. Although health systems
of member states are decentralised, there are still a num-
ber of guidelines that tend to streamline and coordinate
them. Republic of Croatia must harmonise its legislation
and practice with EU conventions and guidelines in the
area of health.
Ever since the European Coal and Steel Community
was established, considerable efforts have been invested
in Europe to deepen its economic integration. There are
several key documents of the EU that have established
the rules on protection from influencing health care sys-
tem and service provision:
• The Treaty of Rome1 established the common market.
As for health protection, Article 152 (5) of the Treaty
of Rome says that Community actions in the field of
public health must entirely respect the responsibilities
of the member states for the organisation and delivery
of health care services2. This way, the Treaty of Rome
has established the principle of subsidiarity.
• The Treaty of Maastricht3 established additional sphe-
res within which European countries could undertake
joint European actions on an intergovernmental basis.
This Treaty gave the EU a more pronounced role in
the development of health policy in Europe. Article 129
of this Treaty provided the EU with a mandate to en-
courage collaboration between member states and, if
necessary, to support their actions in the public health
domain. Furthermore, Article 129 empowered the EU
to spend funds on the European level for health pro-
jects but forbade it to enact laws in terms of harmonis-
ing measures of public health in the member states3.
• In 1997, Article 152 of the Treaty of Amsterdam4, con-
firmed the affirmative responsibility of the EU in or-
der to ensure a high level of protection for human
health in defining and implementing all policies and
activities, and to cooperate with member states to im-
prove public health, prevent diseases, and reduce the
sources of danger to human health. Moreover, the
Treaty of Amsterdam points to the need of developing
health policy at a supranational level.
• The Lisbon Treaty promotes dynamics that might re-
sult in a converging model through some forms of soft
collaboration, especially through the initiatives whose
aim is to establish guides and indicators, through the
exchange of best practices, and by preparing all ele-
ments necessary for periodical monitoring and eva-
luation5. Article 192 (7) of the Treaty on the Func-
tioning of the EU as amended by the Lisbon Treaty
states that EU actions in the field of public health
must fully respect the responsibility of the member
states for defining their health policies and for organis-
ing and providing health services and protection, as
well as for resource allocation5.
The key principle of EU governance is solidarity. In
line with this principle, the EU supports the develop-
ment of social services for all residents of its member
states and the realisation of the »European social mo-
del«. In 2000, EU member states articulated their social
model in the Charter of fundamental rights of the Euro-
pean Union. As for health, the Charter claims that every-
one is entitled to access preventive health care and medi-
cal treatment under the conditions established by natio-
nal laws and practices. Furthermore, it is necessary to
ensure a high level of health care when defining and im-
plementing all EU policies and activities.
Although all EUmember states have their own health
systems and policies, these are directly affected by the
rules and objectives of the EU. There are three distin-
guishable categories of EU measures6. The first category
comprises the acknowledged measures for achieving free
movement of workers, free provision of services, and free
establishment of institutions. The second category refers
to the measures that seek to ensure free movement of
goods, especially pharmaceuticals and medical devices.
The third category includes the measures that arise from
other areas of EU policy, which can be directly related to
health.
In the EU context, there is an issue of how citizens
from one country can enjoy solidarity and provide their
part of income to citizens in other countries6. Many
meetings held between EU member states have revealed
an interest in developing a common position in the area
of financing of health systems and social protection in
health7.
As for the freedom of providing health services to pa-
tients within the EU member states, it is worthwhile
pointing out that besides enjoying the emergency health
care, which is secured through the European Insurance
Card*, when moving across the EU member states they
are also entitled to the following6:
• Clinical treatments in any member state of the EU and
reimbursement of funds once they are back in their re-
spective countries of origin, at prices applicable in that
country. No prior authorisation for reimbursement is
required in accordance with Article 49 of the European
Community Treaty
• Treatment in any EU member state in an identical
manner in which the service is provided to all other cit-
izens of that country (the prices etc.) but with a prior
authorisation by a local institution (Article 22, Regula-
tion 1408/71)
• To require the abovementioned authorisation for the
treatment abroad whenever such a treatment is objec-
tively needed, depending on the patient’s health sta-
tus, or when the treatment is or will be otherwise un-
available in the country for a determinate period of
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time (this right also derives from Article 49 of the Eu-
ropean Community Treaty).
These rights can be exerted by all patients from the
EU states, irrespective of whether their country of domi-
cile applies the reimbursement system (as is the case in
France, Germany, Luxembourg,…), the benefits-in kind
system with contractual physicians and hospitals (as is
the case in the Netherlands), or the system of benefits
provided primarily through public institutions (as is the
case in Great Britain and Italy). Although the laws en-
sure patient mobility, there has not been a reported in-
crease in the number of patients who opt for a treatment
in different member states of the EU.
Assuming that universal coverage with health ser-
vices is the main objective, at least three variables are
needed to define the general interest in the area of health
services that truly belong to the category of common
interest6. The first variable refers to the types of treat-
ments and pharmaceuticals that the system provides for.
These differ from one country to the other and so does
the availability of treatments due to numerous factors.
The most typical examples are the issue of abortion, cos-
metic surgery etc. The second variable refers to the qual-
ity of treatment and varies according to the number and
level of expertise of health professionals, development of
health infrastructure, waiting lists etc. The third vari-
able involves the quality of non-health services, such as
cleaning and accommodation services etc. However, irre-
spective of legal regulations, standards, and all variables,
these have rarely been described in detail in the EU and
they fail to fully define the public interest in the area of
health care. Therefore, it seems that the application of
EU regulations requires introducing a concept of »ser-
vices of public interest« or »public services« and their
precise definition in the area of health care6.
Although infrastructure and other fixed costs are pri-
marily financed through public funds, of late, various
countries have also attempted to attract private invest-
ment. The British initiative of private financing is now
also looked into by other EU countries. It is important to
underscore that the choice of private investors who will
assist in the financing of public hospitals can only be
made in line with the principles of public procurement.
Hospital budgets have a very complex structure and
differ from one country to the other. However, they have
one thing in common: distinguishing between fixed (main-
tenance, heating, staff etc.) and variable costs (directly
related to the volume of their activity). The manner of
calculating variable costs has been under revision in the
past few years in almost all EU member states. In order
to maintain costs and rationalize treatments, there are
three main approaches: (1) advance payments through
the planned budget based on average costs of hospitals
falling into the same category, (2) calculation of average
costs based on Diagnoses Related Groups or equivalent
units of measure where each specific medical condition is
related to a specific treatment and/or length of stay and
(3) allowing efficient hospitals to retain any surplus. Not
only do these measures encourage hospitals to manage fi-
nancial resources in a more efficient manner, but they
also enhance transparency. State aid to hospitals must be
precisely calculated in order to meet the economic re-
quirements of this public service.
Of course, the EU keeps increasing its involvement in
health care governance through the development of new
governance tools. This development coincides with a
growing interest in enhanced welfare, in particular, in re-
spect of health care. The main criticism of new EU gover-
nance refers to its incapacity to protect what is »social«
from what belongs to the »market«8. New mechanisms of
governance include the open method of coordination,
which represents a flexible and participative method of
governance and is nothing like traditional top-down ap-
proaches that are based on rules, and governed and con-
trolled methods. The process of the open method of coor-
dination uses joint learning, benchmarking, best prac-
tices etc. In the context of social or welfare policy, there is
a considerable scepticism in respect of this method, as it
is seen as a way of orienting European welfare policies
towards a non-liberal direction8.
The majority of criticism is nothing but a fear that
new governance is only liberalisation or privatisation of
social institutions in disguise. In Europe, liberalisation
or privatisation in the context of social policy can create a
challenge for the concept of welfare. Some see these new
methods of governance as an opportunity to defend and
maintain these legally grounded social commitments in
the future, whereas others feel that there will be a devia-
tion from these legal commitments and a shift towards a
more liberal orientation of welfare policy. To elaborate on
this criticism, a difference should be made between »con-
tinental European capitalism«, which is based on re-
stricted and socially controlled market economy, and
»Anglo-Saxon capitalism«, which is based on market lib-
eralism. It is much easier to move from continental Euro-
pean capitalism to the Anglo-Saxon one, as the restrictive
elements of European capitalism are easier abandoned
than implemented. However, in the context of health
care policy, there are no arguments to support the idea
that the open method of coordination in health serves
the purpose of undermining continental European social
paradigms or of moving towards the Anglo-Saxon or
neo-liberal model8.
Although formulating and implementing health care
policies is still a task for national policies, the develop-
ment of the internal EU market and the work of EU in-
stitutions (in particular the European Court of Justice)
have transformed the legal environment so much so that
health systems now employ people, purchase goods, fi-
nance services, and organise themselves9. Though it is
difficult to establish a cause-effect relationship, enhan-
ced European integration coincides with market orienta-
tion of service production, that is, with the transfer of
services from public towards private sphere. Collectively
organised and provided services related to transport,
communications, education, and health care can be re-
placed with market production of these services with re-
tention of public financing.
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The EU does not have a political mandate to interfere
with national systems of social security. There is no EU
social model because the differences between member
states are too large10, but the EU can affect the habits of
public expenditure through budgets and by stimulating
growth, in line with the Lisbon strategy. There is a huge
indirect impact exerted through deregulation of national
markets. Furthermore, the influence of the European
Court of Justice is occasional but significant.
Moreover, it can be stated that today there is a new
strategic approach to healthcare as health is considered
as one of integral parts of the EU development strategy.
The concept of health must be included in all relevant
policies. This particularly refers to social and regional de-
velopment, taxation, education, environmental protec-
tion, and research and development policies. The appro-
ach of »health inclusion« must be applied when policies
are drafted, irrespective of the area of interest. In addi-
tion, for it to be fully effective, it must be entirely re-
spected when regional, national, and local policies are de-
veloped.
A new strategy of the European Commission was de-
veloped under the name »Together for health: A Strate-
gic Approach for the EU 2008–2013«. Its objective was to
enhance patients’ safety, citizens’ welfare and solidarity,
and stimulate knowledge and dissemination of health in-
formation. This strategy underscores the importance of
developing such a health care system that will be foun-
ded on common values and principles, reduce inequali-
ties, and include all related policies such as environmen-
tal policy, research and development, regional coopera-
tion, pharmaceutical and other policies. This strategy
also points to the need of strengthening the EU voice on
the global level through cooperation with international
organisations11. In line with the abovementioned, the
key principles that a health care system and a broader
health strategy should be founded on are11:
• A strategy based on common values
• Underlining health as the greatest wealth
• Integrating health in all policies
• Strengthening the EU voice in the area of health and
global health care.
There are three main objectives arising from the
strategy »Together for Health«11: (1) promoting health
for all citizens and its sustainability in a climate of unfa-
vourable demographic conditions of an ageing popula-
tion, (2) improving the system of monitoring and re-
sponding to health threats, and (3) stimulating dynamic
health systems, development and implementation of new
health technologies, fostering care and safety of patients,
and regulating patients’ cross-border rights.
Attempts are made to find new and sustainable ways
of financing and pointing to health as to a priority area
for investment, as well as of stimulating equality and
prevention among EU citizens. There are various initia-
tives within the framework of the European Health
Programme for the period 2008–2013 that promote dis-
ease prevention and health care, raise awareness, and
disseminate information and experience12. To meet the
objectives of this scheme, the funds in the amount of
321.5 million euros have been earmarked for this purpose.
The scheme represents the main instrument of the Euro-
pean Commission for implementing its health strategy.
In November 2011, a proposal for a new health pro-
gramme for the period 2014–2020 entitled »Health for
Growth« was adopted. This programme will continue to
promote health as an integral part of a sustainable and
inclusive economic growth, and will follow the broader
EU development strategy. The new programme covers
four objectives through which it can positively affect eco-
nomic growth and citizens’ health13: (1) addressing the
problem of insufficient financial and human resources
and stimulating innovation to ensure innovative and sus-
tainable health systems, (2) providing an access to infor-
mation and medical expertise within and outside na-
tional borders to ensure an access to better and safer
health care for all EU citizens, (3) recognising, dissemi-
nating and promoting best practices in the area of pre-
vention to prevent disease outbursts and promote good
health, and (4) developing common approaches for better
preparedness and coordination in emergencies to protect
citizens from cross-border health threats.
The new programme intends to help EU countries to
effectively face demographic and economic challenges
and create an environment in which cooperation, coordi-
nation, and innovative solutions for quality, efficiency,
and sustainability improvement are promoted. The bud-
get allocated for the programme »Health for Growth«
amounts to 446 million euros.
Besides the strategies whose only focus is health, the
umbrella strategy for Europe’s development, »Europe
2020«, also contains health, which is indirectly repre-
sented through several different initiatives. A particular
emphasis is placed on innovation arising from the past
activities of research and development, stimulation and
development of telemedicine and similar services, and
stimulation of personalised medicine that could provide
patients with better care and supervision of health14. Im-
proving health and safety of workers is also stimulated.
The European Agency for Safety and Health at Work was
founded in 1996 with the aim of enhancing occupational
safety in EU countries. Each year, there are more than
5.500 serious workplace accidents in the EU, and mil-
lions of workers regularly sustain minor injuries or en-
danger their health15. It is necessary to raise awareness
of workers and employers on the need to protect their
health at work.
Furthermore, WHO Regional Office for Europe ren-
dered a decision on new health care policy for the period
until 2020. The purpose of this new policy known as
»Health 2020« is to strengthen health systems, build in-
frastructure and public health institutions, develop co-
herent and founded policies and solutions for potential
health threats, and achieve sustainable improvements.
As the umbrella policy, it will cover and coordinate all ac-
tions undertaken by the World Health Organisation and
European countries16. The main objectives of “Health
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2020” include16: joining forces of all European member
states to promote health and welfare; creating better
conditions of living, increasing life expectancy, reducing
inequities in health, and coping with demographic chan-
ges; improving health governance; creating common stra-
tegic objectives; speeding up innovation and knowledge-
-sharing and increasing participation of all members of
civil society.
European cohesion policy aims at reducing regional
inequalities by granting financial support from struc-
tural funds. Health and health care have been recognised
as significant elements of welfare and competitiveness
and have been included in the programmes of regional fi-
nancing. Three investment priorities have been high-
lighted: two refer to direct and indirect investments in
health, and the third refers to investments that are out-
side the health sector but are somehow related to it. The
first two areas involve investments in health infrastruc-
ture, e-health, providing access to health care for the
most vulnerable groups, emergency health care, medical
equipment, occupational health and safety, health pro-
motion and disease prevention, and education and train-
ing for health workers. Other investments refer to infor-
mation technology, cross-border cooperation etc. The ef-
fective use of structural funds for improving skills and
competences of labour in health and health infrastruc-
ture development may contribute to improved working
conditions and growing quality of medical services, re-
ducing thus health differences and strengthening cohe-
sion between EU member states17.
There are three main funds within the framework of
the European cohesion policy, which are beneficial to
health care18:
• European Regional Development Fund, which mostly
focuses on financing investments in health infrastruc-
ture and medical equipment, can also provide financ-
ing for investment projects in the area of energy, in-
vestments in the strengthening of institutional infra-
structure etc.
• European social fund most often finances those health
projects that are related to national strategic priori-
ties: for example, increasing employment, reducing
sick leaves, promoting health etc.
• Cohesion fund is one of structural instruments aimed
at reducing regional economic and social differences
between member states. This fund can finance projects
that are directly or indirectly related to health care: for
example, road building, environmental protection etc.
In the period 2007–2012, 5 billion euros have been
earmarked from the European Regional Development
Fund for investments in health infrastructure. The Eu-
ropean Social Fund finances activities in the area of
e-health, health promotion and other similar priority
areas19.
Aiming at streamlining member states and providing
assistance in the area of financing, all in line with cohe-
sion policy, the European Commission has prepared a
Common Strategic Framework – CSF for the period
2014–202020. This document consists of guidelines for
preparing financing, which should add to a better use of
available funds and maximise investment effects. The
Common Strategic Framework will replace the present
guidelines for the Cohesion Fund, the European Rural
Development Fund, the European Regional Development
Fund, the European Social Fund, and the EuropeanMar-
itime and Fisheries Fund and will combine these into a
single set of guidelines that will strengthen coherent fi-
nancial planning. The objective is to direct investments
into development sectors and develop programmes for
better combining and coordinating of the available funds.
National and regional authorities will use this set of
guidelines when developing project applications or apply-
ing for funding from CSF funds. When preparing, imple-
menting, supervising, and assessing a programme, all
member states, potential beneficiaries of CSF funds,
must ensure cooperation and coordination between na-
tional authorities and ministries that are competent for
implementing the allocated funds. The available funds
are intended for the implementation of specific struc-
tural reforms needed to achieve the objectives of EU
2020 development strategy. It is therefore necessary to
ensure the consistency between actions and programmes
financed through CSF funds and the umbrella strategy
for EU development.
Empirical research in this paper was conducted with
the purpose of gaining an insight into potential effects of
Croatia’s accession to the EU on Croatian health care
system.
Research Methods
Methods of research implementation
This research was implemented in the period between
June and October 2011 within the framework of a broa-
der research whose scope was to provide a better under-
standing of the situation and perspectives for future de-
velopment of health care in Croatia. The selected method
of research was a semi-structured interview, which can
be audio recorded, carried out online (chat, e-mail…),
and/or by phone21. The main advantage of the method of
in-depth interviews is that they provide more detailed in-
formation than what is possible to collect through other
methods22. In-depth interviews provide an opportunity
to subjects to express themselves. Many people are flat-
tered to be able to express their opinions and life experi-
ences and that someone listens to them with interest23.
The research on the state of play and perspectives for
a future development of health care system in Croatia
was conducted in three main stages:
1. Background research: investigating the problem by
reviewing the available literature.
2. Construing the main research.
3. Main research that covered 49 subjects.
3.1. Step one: synthesising main topics.
3.2. Step two: analysing.
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3.3. Step three: interpreting results.
3.4. Step four: verifying and reporting.
In line with the objective of this research, we asked
the following research question: How do national health
care systems function in EUmember states and what are
the implications of Croatia’s accession to the EU? Re-
search problems were analysed against today’s situation
(year 2011) and against the perspective on development
and potential future state of play (year 2030). Account
was taken of the research conducted at the EU level on
the development of national health care systems in mem-
ber states by 203024. Besides, analysing both the current
state of play and future perspectives allows for high qual-
ity results to be obtained, which is significant, as these
will later be used to develop recommendations for imple-
menting policies that will minimise potential negative ef-
fects and stimulate potential positive developments.
Participants and Data Processing
The main research involved subjects that were rele-
vant for the established research problems. In-depth in-
terviews were conducted with 49 subjects in the period
from the beginning of June until the end of September
2011: 23 of them were health professionals, 8 were repre-
sentatives of health insurance companies, 10 were repre-
sentatives of pharmaceutical companies and suppliers,
and 8 were representatives of patients’ associations
among which there was a coalition of associations that
covered 70 patients’ associations. As for the choice of
subjects, account was taken of the bias, that is, impartial-
ity was ensured; subjects had to be relevant for the area
of research, and their knowledge had to be such that it
could contribute to determining the implications of Croa-
tia’s accession to the EU for health care in Croatia. Ethi-
cal issues are always present in all types of research25
and all subjects must be informed on the objectives and
main points of the research26. The main ethical issues
that were taken into account during this research were:
(1) subjects’ consent, (2) privacy, and (3) data confidenti-
ality. Each participant in the research was assigned a let-
ter »I« and an adequate ordinal number.
Table 1 shows the main research question and defini-
tions used in its elaboration. The metacode used in the
process of research implementation was designated as
H9. Following the multilevel principle, the pertaining
codes were presented in the same way (Table 1): potential
positive effects of the accession of Croatia to the EU on
Croatian health care and potential negative effects of the
accession of Croatia to the EU on Croatian health care.
Results
Based on the subjects’ opinion, the analysis of poten-
tial effects of Croatia’s accession to the EU on Croatian
health care underscored numerous potential positive and
negative effects and resulted in the recommendations for
maximising positive and minimising negative effects.
There are several potential positive effects; from bet-
ter information flow (I15), growth of Croatian health
care competitiveness (I27, I18) and consequential growth
of service quality, growth of transparency (I27, I2, I47),
introduction of clear benchmarks (I27, I37), improved
monitoring and evaluation (I2), equalisation of quality
and standards (I2, I18, I37, I42, I47), reduced room for
nepotism (I26), to ensured EU funding (I6, I45), faster
registration of innovative and generic drugs (I6), that is,
centralised registration of drugs (I18), increased number
of generics (I46), further integration into pan-European
health care (I5), facilitated exchange of professionals
(I28), improved administrative and political rules of be-
haviour (I36), more control (I41), better organisation
(I47), improved certain segments of health through know-
ledge and experience exchange (I8), and further develop-
ment of those segments in which Croatia has a compara-
tive advantage (I8). Croatia’s accession to the EU will al-
low Croatia to participate in EU projects, drug investiga-
tions, training programmes etc. (I10).
One of potential advantages is also the possibility of
providing health care services to insured persons from
other EU countries (I22), as we boast the advantages of
being a tourist destination and can therefore focus on
further development of health tourism. I45 states the fol-
lowing as a potential advantage: »in the long-term, pro-
cesses of integration of health care will follow the direc-
tion of resource and activity specialisation. This is where
we could find several health niches and exploit the tour-
ist destination aspect of our country…«.
Furthermore, another advantage is a greater avail-
ability of treatments for rare diseases »because due to
high costs for treating such diseases, specific centres will
be organised that will cover the entire EU area« (I28).
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TABLE 1
INDEX OF THEME CODES USED IN THE RESEARCH AND THE FREQUENCIES OF SUB-CODES
theme
metacode sub-codes frequencies
relative share of sub-codes
in the metacode
implications of the Republic of Croatia’s
accession to the EU
H9 139
potential positive effects of the accession of
Republic of Croatia to the EU (2011/2030)
H912011/H912030 56/35 40%/25%
potential negative effects of the accession of
Republic of Croatia to the EU (2011/2030)
H922011/H922030 29/19 21%/14%
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When Croatia joins the EU, it will gain an insight into a
good example of health care informatisation (I5). An-
other advantage of accession is seen in the harmonisa-
tion of rules with other EUmember states (I9). I30 hopes
that Croatian health care will be able to take over the
positive aspects of national health care systems of EU
member states, such as for example opening hospices, en-
hancing the quality of palliative care, and investing more
in prevention and in the training of health staff.
In terms of negative effects of the accession of Repub-
lic of Croatia to the European Union on Croatian health
care, subjects most frequently gave the following exam-
ples: medical doctors and nurses leaving for the EU (I1,
I16, I31, I4, I5, I2, I6, I12, I8, I13, I22, I33, I42, I45), im-
porting health staff (I4, I2, I12, I22) from third non-EU
countries into Croatia (I31), patient outflow, that is, us-
ing health services in other EU countries while the costs
are admitted in the country of origin (I8) (this is, on the
other hand, underlined as a positive effect of the acces-
sion by some – I25), implementing EU decisions that are
not favourable to us (I38, I48), higher costs of health ser-
vices for a large number of citizens (I44), and coping with
a number of insufficiently regulated health care systems
in the EU (I28).
I13 points out that: »upon joining the EU, the pa-
tients will not automatically see improvements, as health
care systems remain under the competence of member
states«, and I19 states that »it is up to us to decide which
health care system we will have«. In this regard, a num-
ber of subjects are of the opinion that there will be no
greater changes once Croatia joins the EU (I23, I32, I33).
The status of pharmaceutical institutions will be uncer-
tain, as this kind of a model is not either known or recog-
nised in the EU (I46) and the possibility of turning these
into another ownership model will be open for discussion.
If Croatian economy improves, potential negative ef-
fects will be minimal (I1). It is necessary to undertake
»due diligence of the system and measures that must be
taken before joining the EU so that we are not taken
aback when the time comes to join the Union« (I3). The
pharmaceutical industry seems to be the most prepared
of all to join the EU (I9).
When asked how they felt Croatian health care was
going to function within the EU framework until 2030,
the subjects listed similar potential problems and bene-
fits to those Croatia would face upon joining the EU next
year. Some subjects were of the opinion that by 2030 Cro-
atian health care: would be similar to the systems in
other EU member states (I11, I34); would be fully in line
with EU standards (I2, I3), or be a part of the EU system
(I27, I5, I7, I37); would be determined by EU laws (13),
but this would not affect the rest of the EU given Croa-
tia’s size (I4). I28 expressed a concern that the effect of
unsuccessful national reforms would still be felt in 2030.
Some subjects hope that Croatian health care will not
experience the problems of »brain drain« of health care
professionals (I1, I15). I12 believes that the »brain drain«
will occur but there will also be an inflow of health staff
that can stir up some positive changes. I19 feels that
»…if we start solving our problems responsibly and im-
mediately, we can reach the EU golden mean quite soon.
Unfortunately, today we are at the very end, aren’t we?«.
I28 warns of »nonmedical and other homeopathic im-
pacts on poorly educated and insufficiently informed
population«. Moreover, I36 believes that except for a few
exceptions, Croatian health care system »has nothing to
offer to the EU«.
Health tourism is seen to become a comparative ad-
vantage over other EU member states (I7, I23, I25). As a
main objective of Croatian health care within the EU un-
til 2030, I8 states the following: »to become a health care
system recognised for its particular segments, which will
make Croatia the country of choice for a number of EU
patients«. Harmonisation with EU health care is seen as
one of positive effects, as it will bring about more order
(I9), the implementation of preventive programmes (I28),
and the achievement of solidary and equally accessible
health care (I33). I47 says: »joining the EU will doubt-
lessly help Croatian medicine to develop and higher stan-
dards to be introduced«.
Some subjects trust that 2030 will reveal poor imple-
mentation of EU acquis in practice (I38, I41, I48) and
that staff and institutions will be concentrated in larger
cities (I38, I48). Table 2 summarises the main expected
effects of Croatia’s accession to the EU on national
health care today and in two decades.
Discussion and Conclusion
The systems of health care and health policies in EU
member states are intertwined in several ways, some of
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TABLE 2
EFFECTS OF THE ACCESSION OF CROATIA TO THE EU ON NATIONAL HEALTH CARE
joining the EU long-term membership in the EU
• better information flow
• growth of Croatian health care competitiveness
• increased quality
• inflow of EU funds
• development of health tourism
• increased migration of health care professionals
• increased costs of health services
• harmonisation with EU standards
• further development of health tourism
• concentration of staff and institutions in larger cities
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them being: the mobility of patients who are in search of
health care services outside their country, migration of
health care professionals, and new findings in the area of
health technologies. The Republic of Croatia’s accession
to the European Union will affect all segments of econ-
omy and society, including the health care system. When
Croatia joins the EU, it will face new rules and priorities
in accordance with the current European health strategy.
This strategy emphasizes the importance of developing
such health care system that will be based on common
values and principles, reducing thus inequalities. The
concept of health must be included in all relevant poli-
cies, especially in the policy of social and regional devel-
opment, taxation, education, environmental protection,
and research and development. It is also important that
the EU voice is strengthened on a global level through
cooperation with international organisations.
Furthermore, Croatia will have the possibility to draw
funds from European cohesion funds. The priority areas
for investment are: health infrastructure, e-health, pro-
viding access to health care for the most vulnerable
groups, emergency medicine, medical equipment, health
and safety at workplace, promotion of health and preven-
tion of diseases, education and training for health profes-
sionals, information technology, cross-border coopera-
tion etc. Aiming at streamlining member states and
providing assistance with strategic planning in the area
of financing, and in accordance with cohesion policy, the
European Commission prepared the Common Strategic
Framework (CSF) for the period 2014–2020. National
and regional authorities will use this framework of gui-
delines when developing project applications, that is,
when applying for CSF financing.
The potential problem of labour migration has also
been pointed out. Free movement of persons within the
EU is one of fundamental rights guaranteed by Commu-
nity law. Free movement of workers within the EU is per-
mitted pursuant to Article 39 of the European Commu-
nity Treaty. Potential advantages of Croatia’s accession
to the EU related to human resources refer to the possi-
bility of providing health services to insured persons
from other EU countries, exploiting thus the advantage
of our tourist destination (that is, the advantages refer to
the development of health tourism). Negative conse-
quences of the accession might be the »brain drain« of
medical doctors, nurses, and other health care profes-
sionals to the EU, and the inflow of other health care per-
sonnel. Labour migration is a particularly significant is-
sue in the EU, as it can result in double-natured effects.
On the one hand, it is a solution to the problem of human
resource shortage in health. On the other hand, however,
an excessive import of labour can push out local labour
from the labour market or can cause a shortage of labour
in the country of emigration. Moreover, cross-border mo-
bility of health workers, besides affecting the volume of
labour in both the recipient country and in the country of
emigration, it also affects the quality and skills of labour,
as well as their distribution17.
When Croatia joins the EU, its health care system will
meet new guidelines on patient safety. The main recom-
mendations refer to: informing patients and involving
them in the process of development of their safety; stim-
ulating safety by training health professionals; monitor-
ing the occurrence of various harmful events to discover
the way of preventing them; developing communication
and technological tools and systems to enhance patient
safety and facilitate collection of information; developing
comparable and significant indicators for identifying prob-
lems that can endanger patients’ health etc. Patient
safety is one of top priorities of the EU. It covers a con-
cept of patient safety that is broader than the mere oc-
currence of undesirable or harmful events related to
health protection. Although EUmember states are at dif-
ferent levels in terms of implementation and develop-
ment of patient safety, there are several initiatives and
recommendations of the main EU bodies that refer to the
coordination of activities related to this area. According
to the results of research by Eurobarometer27, it was
seen that almost half of participants of the research con-
ducted in the EU area believed that there was a danger
for their safety in health care in the country of domicile.
Furthermore, statistical data show that more than 20%
of EU citizens claim that they experienced medical error,
18% claim that the error occurred during hospital treat-
ment, and 11% say that they were prescribed a wrong
medicine28. Creating a clear and systematic access to pa-
tient safety would result in less medical errors by 50 to
70%28. Regional cooperation in Europe is necessary to
ensure a higher level of patient safety, irrespective of
whether they are looking for health care within their
country or in anothermember state. Aiming at further pro-
motion of health and patient safety, in 2008 the European
Network for Patient Safety was established (EUNetPaS).
It seeks to promote the culture of patient safety, ex-
change of experience, training of health professionals on
patient safety, and the implementation of informing and
information-sharing system29. The network is made of
the representatives of EU health professionals (medical
doctors, nurses, pharmacists, and others) and institu-
tional partners who are active in the area of patient
safety (members of national patient safety organisations
and members of the ministries of health). Cooperation
between the mentioned members of the organisation
stimulates the exchange of experience, knowledge, and
best practice to develop common principles of action,
stimulate programme development, and ensure assis-
tance to less well developed countries in the area of pa-
tient safety.
New rules on patient mobility must not be set aside.
Patient mobility within the EU is one of important ele-
ments of integration’s acquis. Its final objective is to en-
sure safe and quality health services for all citizens and
enhanced cooperation and coordination between health
institutions in the member states. The citizens of Croatia
will be granted the option of enjoying the benefits of the
European Insurance Card. As already said, patient mo-
bility within the EU is one of important elements of inte-
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gration’s acquis. However, there is a problem of the ex-
pectation that citizens from one country enjoy solidarity
and at the same time provide a share of their income to
the citizens of other countries. EU cross-border health
care is regulated by Directive 2011/24/EU of the Euro-
pean Parliament and the Council of 9 March 2011 on the
application of patients’ rights in cross-border health ca-
re, which came into force on 24 April 2011. The member
states of the European Union must harmonise their na-
tional legislations with this Directive by 25 October
2013. The coverage of costs of health services that Cro-
atian citizens receive abroad is mostly regulated by bilat-
eral agreements on the coordination of social insurance
concluded with individual EU member states. It is im-
portant to mention that these agreements differ consid-
erably depending on the country partner in terms of vol-
ume of services and personal application and are often
more restrictive than the rules within the EU Directive
on patient mobility.
Furthermore, when joining the EU, there is a need to
harmonise policies on medicines and implantable medi-
cal materials with common EU rules. EU policy on medi-
cines and implantable medical devices is determined at
each member state’s national level but there are some el-
ements that are determined at the level of the Union. For
example, in all countries there are rules that prescribe
that manufacturers must provide a proof of quality and
safety of new medicines and/or devices. All countries reg-
ulate offer and demand on the market for medicines and
implantable medical materials to control total expendi-
ture for medicines30. Regulatory measures for the offer
are mostly directly or indirectly related to pricing, and
they most often include price and profit control, and ref-
erence pricing. Other key issues in the area of policy on
medicines and implantable medical materials include as-
sessing and preventing diseases, setting prices, compen-
sation for expenses, and distribution. The role of the Eu-
ropean Commission in this area continues to grow, as it
encourages member states to respect and abide by EU
laws and principles. It can affect the issues related to na-
tional prices, profit, compensation for expenses, free
movement and competition, and market access through a
harmonised and centralised authorisation procedure by
the European Medicines Agency. The Council Directive
89/105/EEC of 21 December 1988 relating to the trans-
parency of measures regulates the prices of medicinal
products for human use and their inclusion in the na-
tional health insurance systems. It must be underscored
that the Commission is not entitled to set prices and
profit levels in member states; it can only ensure the effi-
ciency and transparency of the process. The establishing
Treaty includes provisions that prohibit introducing un-
necessary and excessive requirements for licensing, which
might restrict and hamper the competition of generics31.
The European Medicines Agency is a decentralised EU
body with head office in London. The main task of this
Agency is to scientifically evaluate drugs manufactured
by pharmaceutical companies that will later be used in
the area of the EU. The Agency cooperates with all 27
member states, the European Parliament, the European
Commission, and other decentralised EU bodies with the
aim of creating a quality regulatory system that will pro-
tect citizens’ health. The approval for new products can
be applied for either through the centralised system of
the Agency or through decentralised system of mutual
recognition. The main problems of the policy on medi-
cines in EU countries are: the lack of innovation in ther-
apy, different and high prices of medicinal products and
implantable medical materials across EU countries, price
as the only measure for quality and the lack of quality
differentiation, increased consumption of drugs, and un-
even availability of drugs and implantable devices across
EU member states17.
There is currently a procedure underway at the Coun-
cil of the European Union for enacting a new Directive
on transparency of measures regulating the prices of medi-
cinal products and their inclusion in the national health
insurance systems, whose aim is to reduce deadlines for
rendering decisions on the requirements for setting pri-
ces, which will also entail sanctions for failure to abide by
deadlines, and the development of new ordinances.
Up to this moment, Croatia has succeeded in harmo-
nising national regulations with EU regulations in the
area of health, in particular as regards: cross-border
health care, regulated professions, prices of medicinal
products and their inclusion in the Essential and Co-Pay
medicines lists of the Croatian Health Insurance Insti-
tute, medical devices, blood, tissues and cells, and envi-
ronmental protection (noise, chemicals and biocide prep-
arations, food, and radiations) and from this point of view,
health sector is considered to be ready to join the EU.
The impact of European integration on health care
systems is limited irrespective of certain rules that affect
health care indirectly or directly. Health is considered to
be one of integral parts of the new EU development
strategy and a significant element of competitiveness.
The area of health is directly and indirectly regulated
through different laws and directives in the area of drug
policy, protection of patients’ rights, public procurement,
patient safety, prevention etc. Health care policy must
ensure and encourage health and health sustainability
for all citizens. With this aim in mind, cooperation be-
tween member states is recommended, as well as the de-
velopment and application of new health technologies,
improvement of the system of monitoring and respond-
ing to health threats, introduction of regulations related
to tobacco, alcohol, mental health and other social and
economic issues that may potentially affect human he-
alth. When defining which direction Croatia will take in
its development, it is necessary to consider EU guidelines
and decisions that are mentioned in the main strategic
documents on health, such as »Together for Health: A
Strategic Approach for the EU 2008–2013«, Europe he-
alth programme for 2008–2013, the new programme for
2014–2020 »Health for growth« that includes the budget
of 446 million euros, health policy »Health 2020« pro-
posed by the World Health Organisation, and a broader
EU development strategy »Europe 2020«. Conclusively,
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concerning the implications of the accession of the Re-
public of Croatia to the European Union, this research
indicates that the accession will bring about better infor-
mation flow, growth of competitiveness of Croatian he-
alth care, increased quality, inflow of EU funds, develop-
ment of health tourism, enhanced labour migration, and
potential increase in the costs of health care services.
Longer functioning within the EU might lead to harmo-
nisation with European standards, further development
of health tourism, but also to the concentration of staff
and institutions in larger cities. When re-thinking and
developing strategies for future development of Croatian
health care, it is necessary to consider all identified ef-
fects and create priorities and measures that will mini-
mise potential negative effects and enhance potential
positive ones.
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IMPLIKACIJE U^LANJENJA REPUBLIKE HRVATSKE U EUROPSKU UNIJU NA HRVATSKI
ZDRAVSTVENI SUSTAV
S A @ E T A K
Ulazak Republike Hrvatske u Europsku uniju (EU) odrazit }e se na sve segmente ekonomije i dru{tva, pa tako i na
zdravstveni sustav te je va`no utvrditi potencijalne efekte u~lanjenja u EU na hrvatski zdravstveni sustav, ali i sprem-
nost ovog sustava na ulazak u navedenu regionalnu ekonomsku integraciju, a {to sve predstavlja glavni doprinos ovog
rada. U radu se identificiraju sva potencijalna podru~ja utjecaja u~lanjenja u EU na hrvatski zdravstveni sustav i anali-
ziraju rezultati provedenog empirijskog istra`ivanja metodom dubinskih intervjua na uzorku od 49 ispitanika, pred-
stavnika zdravstvenih profesionalaca iz javnog i privatnog sektora, zdravstvenih osiguravaju}ih tvrtki, farmaceutskih
tvrtki i veledrogerija te nevladinih udruga, odnosno udruga pacijenata. Pridru`ivanjem EU-u Republika Hrvatska }e se
susresti s: novim pravilima i prioritetima u skladu s aktualnom europskom strategijom zdravstva, mogu}nostima pov-
la~enja sredstava iz europskih kohezijskih fondova, migracijama radne snage, novim smjernicama o sigurnosti i mobil-
nosti pacijenata. S aspekta uskla|ivanja nacionalne regulative s regulativom Europske unije iz podru~ja zdravstvenog
sektora, hrvatski zdravstveni sustav mo`e se ocijeniti spremnim za ulazak u EU. U~lanjenje Republike Hrvatske u EU
mo`e rezultirati boljim protokom informacija, rastom konkurentnosti hrvatskog zdravstvenog sustava, pove}anjem
kvalitete, priljevom sredstava od EU, razvojem zdravstvenog turizma, ali i pove}anjem migracija zdravstvenog osoblja
te potencijalno poskupljenjem zdravstvenih usluga. Funkcioniranje u okviru EU, moglo bi dovesti do uskla|enosti s
europskim standardima i normama, ali i koncentracije kadrova i ustanova u ve}im gradovima.
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